Cargando…
6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.
Autores principales: | Herber, S., Lennard, L., Lilleyman, J. S., Maddocks, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011067/ https://www.ncbi.nlm.nih.gov/pubmed/6954968 |
Ejemplares similares
-
The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.
por: Lennard, L., et al.
Publicado: (1986) -
Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
por: Lilleyman, J. S., et al.
Publicado: (1984) -
Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
por: Lennard, L., et al.
Publicado: (1993) -
Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?
por: Lennard, L., et al.
Publicado: (1995) -
Therapy of Acute Leukaemia: Comparison of Initial Treatment with 6-Mercaptopurine Alone and in Combination with Steroids
por: Bridges, J. M., et al.
Publicado: (1962)